Blueprint Medicines Corporation (BPMC): Price and Financial Metrics
BPMC Price/Volume Stats
| Current price | $94.81 | 52-week high | $121.90 |
| Prev. close | $94.60 | 52-week low | $64.79 |
| Day low | $92.66 | Volume | 566,200 |
| Day high | $95.02 | Avg. volume | 692,467 |
| 50-day MA | $90.00 | Dividend yield | N/A |
| 200-day MA | $95.89 | Market Cap | 6.02B |
BPMC Stock Price Chart Interactive Chart >
Blueprint Medicines Corporation (BPMC) Company Bio
Blueprint Medicines Corporation makes kinase drugs to treat patients with genomically defined diseases. The company was founded in 2008 and is based in Cambridge, Massachusetts.
BPMC Price Returns
| 1-mo | 9.64% |
| 3-mo | 0.27% |
| 6-mo | -7.78% |
| 1-year | 41.49% |
| 3-year | -12.04% |
| 5-year | 24.73% |
| YTD | 2.79% |
| 2023 | 110.55% |
| 2022 | -59.10% |
| 2021 | -4.49% |
| 2020 | 40.00% |
| 2019 | 48.60% |
Continue Researching BPMC
Want to see what other sources are saying about Blueprint Medicines Corp's financials and stock price? Try the links below:Blueprint Medicines Corp (BPMC) Stock Price | Nasdaq
Blueprint Medicines Corp (BPMC) Stock Quote, History and News - Yahoo Finance
Blueprint Medicines Corp (BPMC) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...